{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-072250","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.988940+00:00","generated_at":"2026-06-13T22:32:58.816930+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Annovis Bio shareholders approve doubling authorized common stock to 70M shares at annual meeting","bullets":["Stockholders approved amendment to increase authorized common shares from 35M to 70M.","Charter amendment received 5,699,648 votes for, 633,577 against, and 9,357 abstentions.","All five director nominees elected: Michael Hoffman, Maria Maccecchini, Claudine Bruck, Reid McCarthy, Mark White.","A total of 6,342,582 shares represented at the meeting out of 9,005,131 eligible.","Broker non-votes of 2,307,303 recorded for each director election."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-072250","json":"https://secwatch.observer/filing/0001104659-23-072250.json","markdown":"https://secwatch.observer/filing/0001104659-23-072250.md","text":"https://secwatch.observer/filing/0001104659-23-072250.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/0001104659-23-072250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/tm2318997d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T22:32:58.816930+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0babcf73305fc6a0b77776aa6ed0b7e82b9a0be6","claim":"Annovis Bio, Inc.: Amended certificate of incorporation to increase authorized common shares from 35,000,000 to 70,000,000 (effective 2023-06-15).","evidence_excerpt":"At the Annual Meeting, among other things, the stockholders of the Company approved an amendment to the Annovis Bio, Inc. Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 35,000,000 to 70,000,000 shares (the “Charter Amendment’).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/0001104659-23-072250-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-06-15"}],"fact_type":"governance_change"},{"claim_id":"24243d6ad85b52a27153fd5eedc2d2aa5d675cd5","claim":"Annovis Bio, Inc. shareholders approved Election of Directors at the 2023-06-16 meeting.","evidence_excerpt":"The following director nominees were elected to serve as directors of the Company, with the following votes tabulated: For Withheld Broker Non-Vote Michael Hoffman 3,994,452 40,827 2,307,303 Maria Maccecchini 3,998,045 37,234 2,307,303 Claudine Bruck 3,941,691 93,588 2,307,303 Reid McCarthy 3,993,879 41,400 2,307,303 Mark White 3,987,711 47,568 2,307,303","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/0001104659-23-072250-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"27df2eec46219d9768b98762a1c5720f726e84c8","claim":"Annovis Bio, Inc. shareholders approved Amendment of the 2020 Equity Incentive Plan to increase authorized shares from 35,000,000 to 70,000,000 at the 2023-06-16 meeting.","evidence_excerpt":"The amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 35,000,000 to 70,000,000 was approved, with the following votes tabulated: For Against Abstain 5,699,648 633,577 9,357","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/0001104659-23-072250-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}